Literature DB >> 11408353

N-glucuronidation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N_hydroxy-PhIP by specific human UDP-glucuronosyltransferases.

M A Malfatti1, J S Felton.   

Abstract

Glucuronidation is a major metabolic pathway in the biotransformation of many xenobiotics. Recent studies have shown that in humans, UDP-glucuronosyltransferase (UGT)-mediated glucuronidation plays a critical role in the detoxification of food-borne carcinogenic heterocyclic amines. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), the most abundant carcinogenic heterocyclic amine found in well-cooked meats, has been shown to be extensively glucuronidated in humans. To determine which UGT isozymes are involved in the biotransformation of PhIP and the cytochrome P4501A2-mediated reactive intermediate N-hydroxy-PhIP, microsomes expressing human UGT1A1, -1A4, -1A6 or -1A9 were incubated with PhIP and N-hydroxy-PhIP and the reaction products analyzed by HPLC and ESI-MS. Incubations containing N-hydroxy-PhIP and UGT1A1 expressing microsomes, with an apparent Km of 4.58 microM and a Vmax of 4.18 pmol/min/mg protein, had the highest capacity to convert N-hydroxy-PhIP to N-hydroxy-PhIP-N2-glucuronide. Microsomes expressing UGT1A9 produced N-hydroxy-PhIP-N3-glucuronide at the highest rate with an apparent Km and Vmax of 3.73 microM and 4.07 pmol/min/mg, respectively. A third previously undefined glucuronide accounted for 31% of the total glucuronides formed from the UGT1A4 expressing microsomes. No glucuronide conjugates were detected from microsomes expressing UGT1A6. Incubations containing PhIP as substrate formed direct PhIP-glucuronides in microsomes expressing UGT1A1, UGT1A4 and UGT1A9 but at levels averaging 53-fold lower than when N-hydroxy-PhIP was used as the substrate. Knowing the glucuronidation capacity of the specific UGT isozymes involved in PhIP and N-hydroxy-PhIP glucuronidation should help in determining the individual susceptibility to the potential cancer risk from exposure to PhIP.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408353     DOI: 10.1093/carcin/22.7.1087

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

Review 1.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

2.  In vitro glucuronidation of the antibacterial triclocarban and its oxidative metabolites.

Authors:  N H Schebb; B Franze; R Maul; A Ranganathan; B D Hammock
Journal:  Drug Metab Dispos       Date:  2011-09-27       Impact factor: 3.922

3.  A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach.

Authors:  Chi Chen; Xiaochao Ma; Michael A Malfatti; Kristopher W Krausz; Shioko Kimura; James S Felton; Jeffrey R Idle; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2007-02-06       Impact factor: 3.739

4.  Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.

Authors:  Keelia Rhoads; James C Sacco; Nicholas Drescher; Amos Wong; Lauren A Trepanier
Journal:  Toxicol Sci       Date:  2011-03-29       Impact factor: 4.849

5.  Expression of UDP-glucuronosyltransferase 1A, nuclear factor erythroid-E2-related factor 2 and Kelch-like ECH-associated protein 1 in colonic mucosa, adenoma and adenocarcinoma tissue.

Authors:  Min Wang; Ying-Ying Qi; Shuo Chen; DE-Feng Sun; Shuai Wang; Jian Chen; Yan-Qing Li; Wei Han; Xiao-Yun Yang
Journal:  Oncol Lett       Date:  2012-08-06       Impact factor: 2.967

Review 6.  Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

Authors:  Robert J Turesky; Loic Le Marchand
Journal:  Chem Res Toxicol       Date:  2011-06-20       Impact factor: 3.739

7.  Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor.

Authors:  Wen Xie; Mei-Fei Yeuh; Anna Radominska-Pandya; Simrat P S Saini; Yoichi Negishi; Bobbie Sue Bottroff; Geraldine Y Cabrera; Robert H Tukey; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

8.  Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan B Okey; Patricia A Harper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  A pharmacogenetics study of the human glucuronosyltransferase UGT1A4.

Authors:  Marie-Odile Benoit-Biancamano; Jean-Philippe Adam; Olivier Bernard; Michael H Court; Marie-Hélène Leblanc; Patrick Caron; Chantal Guillemette
Journal:  Pharmacogenet Genomics       Date:  2009-12       Impact factor: 2.089

10.  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Sheri Trudeau; Andrew Rundle; Satoru Takahashi; Tomoyuki Shirai; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2013-03-09       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.